A ntigen receptor diversity due to V(D)J recombination is the hallmark of the adaptive immune system in jawed vertebrates. V(D)J recombination is mediated by the lymphoid-specific recombinase proteins RAG-1 and RAG-2, which are expressed in developing T and B cells and recognize highly conserved recombination signal sequences (RSSs) that flank the V, D, and J gene segments of Ag receptor genes (1) . During T cell development, four Ag receptor genes, Tcra, Tcrb, Tcrg, and Tcrd, undergo rearrangement to direct the expression of ab or gd TCRs (2) . The Tcrb, Tcrg, and Tcrd genes rearrange at the CD4 2 CD8 2 double negative (DN) stage of T cell development, whereas Tcra recombination occurs at the CD4 + CD8 + double positive (DP) stage. In the mouse genome, Tcrb is located on chromosome 6 and Tcrg is located on chromosome 13, whereas Tcra and Tcrd share a single genetic locus on chromosome 14 (Tcra/Tcrd). Given that Tcra and Tcrd gene segments rearrange during different developmental stages and encode TCRs expressed on distinct lineages of T cells, their presence in a single genetic locus poses unique regulatory challenges.
The Tcra/Tcrd locus spans ∼1.6 megabases comprising ∼100 V gene segments, 2 Dd and 2 Jd gene segments, 1 Cd gene segment, 61 Ja gene segments, and 1 Ca gene segment (3) (4) (5) . The large pool of V gene segments is situated upstream of Dd, Jd, and Ja gene segments and could therefore contribute to both rearranged Tcrd (V-Dd-Jd) and Tcra (V-Ja) genes. However, whereas almost all V gene segments rearrange to Ja segments and contribute to the Tcra repertoire, only a subset rearrange to Dd segments and contribute to the Tcrd repertoire. Among the latter, several (TRDV1, TRDV2-1, TRDV2-2, TRDV4, TRDV5) are designated as exclusive Vd gene segments; these are all clustered within 250 kb of the Dd gene segments. Several additional V gene segments are designated as both Vd and Va gene segments (TRAV21/DV12, TRAV13-4/DV7, TRAV6-7/DV9, TRAV4-4/DV10, TRAV14D-3/ DV8, TRAV16D/DV11, and four members of the TRAV15/DV6 family) (4); these are distributed across .1 megabase of DNA and are interspersed among Va gene segments. The factors that direct particular V gene segments for usage as Vd or Va gene segments remain unknown.
One factor that may contribute to the specificity of V gene segment usage is chromosomal position. However, as noted earlier, only a subset of Vd gene segments are located in proximity to Dd gene segments, whereas others are much more distant and are surrounded by Va gene segments. Alternatively, developmentally regulated accessibility of V gene segments to the RAG recombinase could identify Vd gene segments. Indeed, in DN thymocytes, the most commonly used Vd gene segments were shown to display elevated germline transcription and histone modifications as compared with Va gene segments (6) . Because previous studies have shown that RSSs themselves can provide specificity beyond 12/23 restriction (7, 8) , an additional possibility is that Va and Vd 23RSSs may differ in their ability to undergo recombination with Dd 12 RSSs. However, direct tests of this hypothesis identified no such restrictions, suggesting accessibility as the more likely explanation (9) . Two major cis-regulatory elements, the Tcrd enhancer (Ed) and the Tcra enhancer, are known to control Tcrd and Tcra recombination events, respectively (10, 11) . Ed is activated in DN thymocytes and contributes to both Vd-Dd and Dd-Jd recombination (11) . However, Ed cannot function over long distances (12) and in adult thymocytes its effects appear to be limited to Dd, Jd, and Cd gene segments, as well as TRDV5 (13) . Although its influence extends as far as 55 kb to TRDV4 in fetal thymocytes, it does not provide accessibility to more distal Vd gene segments in fetal or adult thymocytes (13) . Therefore, if Vd gene segments are specified by their chromatin accessibility in DN thymocytes, that accessibility must be directed by cis-elements other than Ed.
The TRAV15/DV6 family is efficiently used in Tcrd recombination and also participates in Tcra recombination. In strain 129 mice, this family is composed of four members: TRAV15D-1/ DV6D-1, TRAV15D-2/DV6D-2, TRAV15-1/DV6-1, and TRAV15-2/ DV6-2. The TRAV12 family, which is used almost exclusively in Tcra recombination, is composed of TRAV12D-1, TRAV12D-2, TRAV12D-3, TRAV12-1, TRAV12-2, and TRAV12-3 (14-17). TRAV15/DV6 but not TRAV12 family V gene segments show evidence of accessibility in DN thymocytes (6) , suggesting a correlation between V segment accessibility and usage. However, a causal relation between accessibility and usage has not been established. In this study, we formally tested this relation, hypothesizing that TRAV15/DV6 gene segment promoters provide local chromatin accessibility in DN thymocytes that enables efficient V segment usage in Tcrd recombination. Specifically, we asked whether a TRAV15 promoter could confer on a TRAV12 gene segment the ability to rearrange to Dd gene segments in DN thymocytes. Our results show that the presence of a knock-in 1.74kb promoter region of TRAV15-1/DV6-1 caused increases in transcription and chromatin accessibility of the TRAV12-2 gene segment in DN thymocytes, and significantly enhanced the usage of TRAV12-2 in Tcrd recombination events.
Materials and Methods

Mice
The targeting construct, embryonal stem (ES) cell clones, and mice were generated at TaconicArtemis GmbH (Germany). A 1742-bp genomic region including upstream sequences, exon 1, intron 1, and 5 bp of exon 2 of TRAV15-1/DV6-1 (nt 945193-946934 of GenBank accession number NT_039614, http://www.ncbi.nlm.nih.gov/genbank) was used to replace the analogous portion of TRAV12-2 (nt 1007954-1009697) by homologous recombination. The targeting vector was generated by PCR amplification of the insert region, as well as 3.0-and 6.7-kb homology arms from 129/SvEvTac ES cell genomic DNA. The fragments were cloned into a proprietary vector backbone. The targeting vector was electroporated into a proprietary 129S6/SvEvTac ES cell line (ART129S626), and targeted clones were isolated using positive (neomycin resistance) and negative (thymidine kinase) selection. The targeting frequency was 14.7%. The flippase recognition target site-flanked neomycin resistance gene was excised by transfection with pCAG-Flpe-pA. Successfully deleted clones were used to generate chimeric mice using blastocysts of superovulated BALB/c females. Chimeric mice were bred to 129 for several generations and were then intercrossed to generate homozygous 15-12 mice, or were further bred to Rag2 2/2 mice on a 129 background to generate homozygous Rag2 2/2 mice. All mice were used in accordance with protocols approved by the Duke University Animal Care and Use Committee and the German Animal Welfare Act.
Germline transcription
RNA was prepared from total thymocytes of 3-to 4-wk-old Rag2 2/2 or homozygous 15-12 Rag2 2/2 mice using TRIzol (Life Technologies). After DNase I treatment of the RNA samples, cDNA synthesis was carried out using SuperScript III (Invitrogen) and random hexamer primers according to the manufacturer's protocol. SYBR Green real-time PCR (Qiagen) was performed using a Roche LightCycler 480 under the following conditions: 95˚C for 5 min followed by 45 cycles of 95˚C for 10 s, 62˚C for 30 s. Primers are listed in Supplemental Table I .
Chromatin immunoprecipitation
Chromatin was prepared from total thymocytes of 3-to 4-wk-old Rag2 2/2 or homozygous 15-12 Rag2 2/2 mice and was immunoprecipitated using Abs specific for acetylated histone H3 (H3ac; Millipore, 06-599), trimethylated histone H3 lysine 4 (H3K4me3; ab1012; Abcam) or control rabbit IgG (ab-105-c; R&D Systems) following a protocol described previously (13) . Immunoprecipitated and input samples were quantified by SYBR green real-time PCR as described earlier. Experimental values were expressed as bound/input and were normalized to values for b 2 -microglobulin in each sample.
Cell sorting
DN and DP thymocytes were collected from 3-to 4-wk-old mice by cell sorting. To isolate the DN2/DN3 fraction, we stained total thymocytes with PECy5-conjugated Abs against CD4 (100410; BioLegend) and CD8 (100710; BioLegend) for 20 min on ice. Cells were washed twice with RPMI 1640 containing 10% FBS, after which CD4 + and CD8 + cells were removed using Dynabeads (Life Technologies) according to the manufacturer's instructions. Remaining thymocytes were stained with FITCconjugated Ab against CD25 (102006; BioLegend), allophycocyaninconjugated Ab against CD44 (103012; BioLegend), PECy5-conjugated 7AAD (A1310; Invitrogen), and PECy5-conjugated Abs against CD4, CD8, CD3ε (100310; BioLegend), B220 (103210; BioLegend), Mac1 (15-0112-830; BioLegend), Gr1 (108410; BioLegend), and Ter119 (106210; BioLegend) for 20 min on ice. The stained thymocytes were washed and CD25 + PECy5 2 cells were obtained by cell sorting. DP thymocytes were collected by sorting as previously described (18) .
Recombination assays
Genomic DNA was prepared according to standard procedures. RNA isolation and cDNA synthesis were performed as described earlier. To create plasmid standards for quantification of rearrangements, we amplified TRAV15-TRDC and TRAV12-TRDC products by PCR from 15-12 cDNA using primers listed in Supplemental Table I under the following conditions: 95˚C for 5 min followed by 25 cycles of 95˚C for 30s, 57˚C for 30 s, and 72˚C for 30 s, with a final extension of 72˚C for 5 min. TRAV15-TRDC and TRAV12-DC PCR products were then cloned into a TOPO PCR Cloning Vector PCR 2.1 (Life Technologies). The resulting plasmids were quantified by PicoGreen (Life Technologies), were serially diluted into Rag2 2/2 Tcrb transgenic genomic DNA to be used as recombination standards, and were further normalized to each other by SYBR green realtime PCR using primers that anneal to the PCR 2.1 vector backbone. TRAV12-DJ1 and TRAV15-DJ1 recombination was then measured in DN thymocyte genomic DNA samples and in the plasmid standards by Taq-Man real-time PCR using primers and probes listed in Supplemental  Table I under the following conditions: 95˚C for 10 min followed by 48 cycles of 95˚C for 10 s, 62˚C for 30 s. Values for genomic DNA amplification in wild-type and 15-12 were normalized to each other by SYBR green real-time PCR amplification of Cd14. Absolute numbers of rearranged products were then determined based on the calculated molar amounts of input genomic DNA and plasmid standards.
TRAV12-DJ1 and TRAV15-DJ1 recombination was measured in cDNA samples by TaqMan PCR under conditions outlined earlier. Experimental values were normalized to those for b-actin (Actb) in different samples.
Results
To understand whether the TRAV15/DV6 promoter region enables TRAV15/DV6 participation in Tcrd recombination in DN thymocytes, we used gene targeting to replace the promoter of a TRAV12 family member with one from a TRAV15/DV6 family member. Previous studies had shown that TRAV15/DV6 family members (then called ADV7) participate in Tcrd and, to a lesser extent, in Tcra rearrangements, whereas TRAV12 family members (then called ADV8 or Va8) participate in Tcra rearrangement almost exclusively (14) (15) (16) (17) . TRAV15-1/DV6-1 and TRAV12-2 are separated by only 62 kb at a distance of .500 kb from Dd1 (Fig. 1A) . We replaced a 1.74-kb region of TRAV12-2 with the equivalent portion of TRAV15-1/DV6-1, so that the hybrid gene contained the following TRAV15-1/DV6-1 sequences: 1460 bp of promoter and 59 untranslated sequences, 32 bp of exon 1, 230 bp of intron 1, and 5 bp of exon 2 (Fig. 1B-D) . The intron and splice sites of TRAV15-1/DV6-1 were kept intact to minimize the likelihood that splicing of the hybrid gene would be disrupted. The knock-in mouse line generated (called 15-12) has a wild-type version of TRAV15-1/DV6-1 and the TRAV15-1/DV6-1:TRAV12-2 hybrid gene located 62 kb downstream.
We asked whether the hybrid TRAV12-2 gene segment was regulated differently than the wild-type TRAV12-2 gene segment by analyzing germline transcription and chromatin modifications of both gene segments on a Rag2 2/2 background. TRAV12-2 germline transcription in Rag2 2/2 DN thymocytes was significantly higher on 15-12 as compared with wild-type alleles, whereas TRAV15 family and total Cd transcripts were comparable ( Fig. 2A ). Small increases in germline transcription of TRAV4-3, 29 kb upstream of TRAV12-2, and of TRAV9-3, 5 kb downstream of TRAV12-2, were not statistically significant ( Fig. 2A) .
We assessed H3ac and histone H3 lysine 4 trimethylation (H3K4me3) as measures of active chromatin that are thought to reflect transcription and accessibility of Ag receptor gene segments to the RAG recombinase (19, 20) . Transcription-dependent H3K4me3 deposition has been tied directly to RAG-mediated recombination because this mark has been shown to facilitate RAG2 protein binding to chromatin via its plant homeodomain finger and to facilitate RAG2 catalytic activity (21) (22) (23) . We prepared chromatin from DN thymocytes of Rag2 2/2 mice carrying wild-type or 15-12 alleles and immunoprecipitated H3ac or H3K4me3 chromatin followed by PCR using TRAV12-2 primers. In comparison with TRAV12-2 on wildtype alleles, TRAV12-2 on 15-12 alleles showed significantly greater levels of H3ac (Fig. 2B) and H3K4me3 (Fig. 2C) . Thus, the TRAV15-1/DV6-1 promoter region conferred to the hybrid gene segment elevated germline transcription and histone modifications that are typical of TRAV15-1/DV6-1 in DN thymocytes (6) .
We determined whether these promoter-dependent changes in germline transcription and histone modifications translated to changes in TRAV12-2 recombination on 15-12 alleles. To accomplish this, we first amplified and cloned PCR products representing TRAV12-TRDC and TRAV15/DV6-TRDC recombination events from 15-12 thymus cDNA. We then used the resulting plasmids as standards to design a highly quantitative PCR assay to measure TRAV12 and TRAV15/DV6 recombination to TRDJ1 in genomic DNA of wild-type and 15-12 DN thymocytes. We confirmed a dramatic difference between TRAV15/DV6 and TRAV12 rearrangement to TRDJ1 in DN thymocytes of 129 mice, because the former displayed 387 rearrangements per 10,000 genomes, whereas the latter displayed only 6 rearrangements per 10,000 genomes (Fig. 3A) . As expected, TRAV15/DV6-TRDJ1 products were not significantly different in 15-12 as compared with wild-type DN thymocytes. However, TRAV12-TRDJ1 products were ∼24-fold more abundant in 15-12 as compared with wild-type ( Fig. 3A) . Although the frequency of TRAV12-TRDJ1 rearrangement in 15-12 thymocytes was only ∼1/3 that of TRAV15/DV6-TRDJ1, we note that four TRAV15/DV6-TRDJ1 family members may contribute to the TRAV15/DV6-TRDJ1 PCR signal. By contrast, only the hybrid TRAV12-2 gene should contribute to the TRAV12-TRDJ1 PCR signal. Thus, the activation of TRAV12-TRDJ1 rearrangement in 15-12 thymocytes is substantial.
We confirmed the upregulation of TRAV12-2 usage in 15-12 DN thymocytes by analysis of cDNA prepared from wild-type and 15-12 mice (Fig. 3B) . The results showed that TRAV15/DV6-TRDJ1 transcripts were comparable in wild-type and 15-12 DN thymocytes, whereas TRAV12-TRDJ1 transcripts were ∼4.5-fold higher in 15-12 than in wild-type samples. The smaller increase in TRAV12 usage in cDNA as compared with genomic DNA could reflect perturbations in hybrid gene transcription, splicing, or transcript stability. Nevertheless, the overall trend was consistent with the more direct and more quantitative analysis of rearrangement in genomic DNA (Fig. 3A) . To determine whether the TRAV12-TRDJ1 recombination products in 15-12 cDNA samples originated from the hybrid gene, we used a nested PCR approach. We first amplified TRAV15-1/DV6-1-TRDC products from wild-type and 15-12 cDNA samples using a TRAV15-1/DV6-1 exon 1 primer that recognizes both the wild-type TRAV15-1/DV6-1 and the hybrid gene. Gelpurified PCR products were then used as templates for second-round amplification with TRAV12 and TRDJ1 primers. The results showed that TRAV12-TRDJ1 recombination products were only detected in 15-12 samples (Fig. 3C) , implying that TRAV12 usage was driven by the hybrid gene.
Discussion
Our findings demonstrate that usage of TRAV15/DV6 family V gene segments for Tcrd recombination in DN thymocytes is regulated, at least in part, by intrinsic features of TRAV15/DV6 promoters. Because the TRAV15-1/DV6-1 promoter region conferred increased germline transcription and histone modifications to TRAV12-2 in DN thymocytes, our data offer the best evidence yet that Tcra/Tcrd locus Vd gene segments are defined by the accessibility of their local chromatin environment to the RAG recombinase in DN thymocytes. At least in the case of TRAV15/ DV6 family V gene segments, this accessibility is independent of Ed (13) . Thus, accessibility must be determined solely by local promoter sequences, or by local promoter sequences together with undiscovered long-distance regulatory elements. Our experiments also rule out any specificity contributed by RSSs or chromosomal position, at least in the case of TRAV15/DV6.
Although the developmental regulation of gene segment usage at Ag receptor loci has been the subject of intensive investigation for many years, mechanistic studies of V gene segment recombination have been rather limited. Deletion of the Vb13 promoter substantially impaired Vb13 rearrangement, implicating the V gene segment promoter as an important determinant of V gene rearrangement in vivo (24) . A recent study assessed the molecular correlates of Vb usage and supported major roles for RSS quality and an accessible chromatin environment, as defined by RNA polymerase II and active histone marks such as H3Ac and H3K4me3 (25) . Similar conclusions were drawn regarding V H usage, although for a subset of V H gene segments, proximity to CTCF and cohesin binding sites seemed critical (26) . Nevertheless, we are aware of only one set of studies that directly examined the parameters accounting for developmentally programmed usage of V gene segments. That work showed that within the Tcrg Cg1 locus, usage of Vg genes in early fetal thymocytes is determined by their relative positioning, whereas their usage in adults is determined by their promoter sequences (27) (28) (29) . Although our data rule out a role for chromosomal position in specifying TRAV15/DV6 usage, chromosomal positioning near Dd could contribute to exclusive use of some Vd gene segments in Tcrd rearrangements.
TRAV15/DV6 promoters could enable efficient recombination to Dd gene segments by hosting the binding of specific transcription factors that mediate their activation at the DN stage. In addition, these promoters could efficiently mediate looping that positions TRAV15/DV6 family members near Dd gene segments in threedimensional space in DN thymocytes; such positioning should be facilitated by the relatively contracted conformation of the Tcra/ Tcrd locus in DN thymocytes (30) . In either case, we note that TRAV15/DV6 family promoter regions display remarkably high levels of DNA sequence conservation as compared with some other V gene segment families. The 2.7-kb regions upstream of TRAV15 family exons 1 display 62% homology with each other, whereas the equivalent regions of TRAV4, TRAV12, TRAV13, and TRAV14 family members show 19, 46, 18, and 15% conservation, respectively. These conserved TRAV15/DV6 sequences are likely to recruit a common array of factors that specify their distinct developmental program.
Given that CTCF and cohesin bind to many Tcra/Tcrd locus V segment promoters and are important regulators of Va-Ja recombination (31, 32) , the disposition of CTCF and cohesin binding in the vicinity of TRAV15-1/DV6-1 and TRAV12-2 is of some interest. Notably, in both DN and DP thymocytes, CTCF and cohesin bind strongly to a promoter site ∼100 bp upstream of the first TRAV12-2 exon and to a second site located 1.8 kb further upstream (32) . In contrast, the TRAV15-1/DV6-1 is devoid of nearby CTCF and cohesin binding. Our promoter replacement eliminated the binding site proximal to the first TRAV12-2 exon, but left the distal site intact and introduced no new binding sites for CTCF and cohesin. Thus, CTCF and cohesin binding cannot readily explain the ability of the TRAV15-1/DV6-1 promoter to confer Vd status to TRAV12-2. Consistent with this, Dd and Jd segments and Ed also lack substantial binding of CTCF and cohesin (32) . These considerations do not eliminate the possibility that the TRAV15-1/DV6-1 promoter could regulate recombination in DN thymocytes in part by facilitating long-distance looping. However, this looping would likely be independent of CTCF and cohesin, and would likely occur at quite low frequency, because we have been unable to detect contact between Ed and distant Vd gene segments by chromosome conformation capture approaches. Further work will be required to more fully understand the unique features of TRAV15/DV6 promoters that confer Vd status to linked V gene segments.
1 Supplementary Table 1 Oligonucleotides use as PCR primers and probes 
